A major therapeutic and commercial opportunity awaits TTHX1114 in age-related corneal diseases. In the US and Europe, approximately 600,000 people have Fuchs dystrophy, the most common type of CED ...

Research led by UCL Institute of Ophthalmology and supported by NIHR Moorfields Biomedical Research Centre, investigated a ...